Business Context and Reporting Period
This Form 8-K is filed by Tivic Health Systems, Inc. (not Valion Bio, Inc.) on August 27, 2025. The report addresses administrative changes regarding the company's transfer agent and warrant agent, effective August 30, 2025.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is an "Other Events" filing and contains no financial performance data.
Material Changes
- Transfer Agent Change: The Company appointed Odyssey Transfer and Trust Company ("Odyssey") as its new transfer agent and registrar, replacing Equiniti Trust Company, LLC ("Equiniti").
- Warrant Agent Change: Odyssey replaced Equiniti as the successor warrant agent for Series B Warrants issued on May 13, 2024.
- Effective Date: All share records and agent responsibilities transfer on or before August 30, 2025.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is strictly procedural regarding the change of service providers.
Investor Verification Checklist
- Verify the correct registrant name is Tivic Health Systems, Inc. (Ticker: TIVC), not Valion Bio, Inc.
- Confirm the effective date of the transfer agent change is August 30, 2025.
- Ensure shareholder records are updated to reflect Odyssey Transfer and Trust Company as the new registrar.
- Review the impact of the warrant agent change on Series B Warrants issued in May 2024.